Abstract

AMH is a sensitive marker of ovarian reserve and a good predictor of poor or excessive response following controlled ovarian stimulation. We performed a systematic review of the medical literature and meta-analysis to assess whether AMH is a predictor of implantation and/or clinical pregnancy (CP) in women undergoing ART.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.